• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correspondence on Editorial regarding "Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations".关于“使用外周胰岛素抵抗指数筛查和预测非酒精性脂肪性肝病：潜在益处和局限性”的社论的通信
Clin Mol Hepatol. 2023 Jan;29(1):185-187. doi: 10.3350/cmh.2022.0375. Epub 2022 Nov 10.
2
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.使用外周胰岛素抵抗指数筛查和预测非酒精性脂肪性肝病：潜在益处与局限性
Clin Mol Hepatol. 2022 Oct;28(4):802-805. doi: 10.3350/cmh.2022.0249. Epub 2022 Sep 14.
3
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.代谢评分对胰岛素抵抗预测韩国成年人非酒精性脂肪性肝病发病的作用。
Clin Mol Hepatol. 2022 Oct;28(4):814-826. doi: 10.3350/cmh.2022.0099. Epub 2022 Jun 9.
4
The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.不同胰岛素抵抗指数在评估超重/肥胖儿童非酒精性脂肪性肝病中的价值。
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9. doi: 10.1016/j.dsx.2013.10.008. Epub 2013 Nov 14.
5
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
6
Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.HOMA-IR和QUICKI在代谢综合征及非酒精性脂肪性肝病诊断中的最佳切点：一项基于人群的研究。
J Diabetes Complications. 2016 Mar;30(2):269-74. doi: 10.1016/j.jdiacomp.2015.11.019. Epub 2015 Dec 2.
7
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.非肥胖中国人群胰岛素抵抗指数代谢评分与非酒精性脂肪性肝病的剂量-反应关系：基于人群队列研究的回顾性证据。
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
8
Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome.绝经前代谢综合征妇女的胰岛素抵抗与非酒精性脂肪性肝病。
Horm Metab Res. 2021 Feb;53(2):100-104. doi: 10.1055/a-1341-9710. Epub 2021 Jan 29.
9
Correspondence on Letter regarding "The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults".关于“胰岛素抵抗代谢评分对韩国成年人新发非酒精性脂肪性肝病预测的有用性”的信件往来
Clin Mol Hepatol. 2023 Jan;29(1):179-181. doi: 10.3350/cmh.2022.0409. Epub 2022 Nov 22.
10
Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.家族性地中海热中非酒精性脂肪性肝病的患病率。
Endocr Metab Immune Disord Drug Targets. 2020;20(6):952-958. doi: 10.2174/1871530320666200220125829.

本文引用的文献

1
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.采用分层贝叶斯方法预测 2040 年非酒精性脂肪性肝病的全球患病率。
Clin Mol Hepatol. 2022 Oct;28(4):841-850. doi: 10.3350/cmh.2022.0239. Epub 2022 Sep 19.
2
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.使用外周胰岛素抵抗指数筛查和预测非酒精性脂肪性肝病：潜在益处与局限性
Clin Mol Hepatol. 2022 Oct;28(4):802-805. doi: 10.3350/cmh.2022.0249. Epub 2022 Sep 14.
3
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.代谢性胰岛素抵抗评分与非酒精性脂肪性肝病患者发生进展性肝纤维化呈负相关。
Nutrients. 2022 Jul 24;14(15):3039. doi: 10.3390/nu14153039.
4
Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?非酒精性脂肪性肝病会使患者易患颈动脉粥样硬化和缺血性中风吗？
Clin Mol Hepatol. 2022 Jul;28(3):473-477. doi: 10.3350/cmh.2022.0155. Epub 2022 Jun 22.
5
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.糖尿病和糖尿病前期对非酒精性脂肪性肝病的患病率、并发症和死亡率的影响。
Clin Mol Hepatol. 2022 Jul;28(3):565-574. doi: 10.3350/cmh.2022.0096. Epub 2022 May 19.
6
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.非酒精性脂肪肝疾病与老年人晚年痴呆症发病的相关性。
Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17.
7
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.非肥胖中国人群胰岛素抵抗指数代谢评分与非酒精性脂肪性肝病的剂量-反应关系：基于人群队列研究的回顾性证据。
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
8
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.KASL临床实践指南：非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
9
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.青少年 2 型糖尿病患者存在肝脏、外周和脂肪组织胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E186-E195. doi: 10.1152/ajpendo.00258.2018. Epub 2018 Dec 18.
10
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.

Correspondence on Editorial regarding "Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations".

作者信息

Lee Jun-Hyuk, Park Kyongmin, Lee Hye Sun, Park Hoon-Ki, Han Jee Hye, Ahn Sang Bong

机构信息

Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.

Department of Medicine, Graduate School of Hanyang University, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2023 Jan;29(1):185-187. doi: 10.3350/cmh.2022.0375. Epub 2022 Nov 10.

DOI:10.3350/cmh.2022.0375
PMID:36353767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9845667/
Abstract
摘要